Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
ALA:ASX
Arovella Therapeutics Ltd
A$0.077
0.00%
(0.00) 1D
Apr 24, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ALA...
Open
A$0.08
High
A$0.08
Low
A$0.08
Mkt. cap
89.59M
Avg. vol.
752.08K
Volume
380.04K
52-wk high
A$0.12
52-wk low
A$0.06
EPS
-A$0.01
Shares outstanding
1.21B
No. of employees
14
News stories
From sources across the web
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
SectorPharmaceutical industry
Last report
Jan 22, 2026
Fiscal Period
Q2 2026
Normalized EPS / Estimate
-/ -AUD
Revenue / Estimate
1.60M/ (- est.)AUD
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
415.00
415.00
1.60M
1.60M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.97M
1.97M
1.37M
1.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
523.20K
523.20K
721.91K
721.91K
Operating expense
3.10M
3.10M
2.75M
2.75M
Total operating expenses
3.10M
3.10M
2.75M
2.75M
Operating income
-3.10M
-3.10M
-1.15M
-1.15M
Other non operating income
-
-
-
-
EBT including unusual items
-3.02M
-3.02M
-939.35K
-939.35K
EBT excluding unusual items
-3.02M
-3.02M
-939.35K
-939.35K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
402.20K
402.20K
449.58K
449.58K
Net income
-3.02M
-3.02M
-939.35K
-939.35K
Net profit margin
-728,624.58%
-728,624.58%
-58.55%
-58.55%
Earnings per share
-
-
-
-
Interest and investment income
72.24K
72.24K
207.81K
207.81K
Interest expense
-
-
-
-
Net interest expenses
72.24K
72.24K
207.81K
207.81K
Depreciation and amortization charges
29.20K
29.20K
29.58K
29.58K
EBITDA
-3.07M
-3.07M
-1.12M
-1.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more